NCT00002178View on ClinicalTrials.gov

A Phase IIIB Open-Label, Comparative Study to Evaluate Saquinavir Soft Gel Capsule (SGC) Treatment in Combination With Other Antiretrovirals in HIV-1 Infected Antiretroviral-Naive Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

375

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Ritonavir

DRUG

Nelfinavir mesylate

DRUG

Saquinavir

DRUG

Delavirdine mesylate

Trial Locations (2)

90048

Dr Charles Farthing, Los Angeles

02445

Community Research Initiative, Brookline

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY